Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
8axJqtZt0cc9UQbB
